LAVA Therapeutics N.V. (LVTX) Stock Analysis
DELISTED 2025
What happened to LAVA Therapeutics N.V. (LVTX) stock?
LAVA Therapeutics N.V. (LVTX) no longer trades on public markets. It was delisted in November 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- November 2025
- Last recorded price (historical):
- $1.74 (last quote on record before the November 2025 delisting; historical, not a current quote)
Market cap $45.8M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
LAVA Therapeutics N.V. (LVTX). LAVA Therapeutics N.V. is a clinical-stage immuno-oncology company focused on developing cancer treatments through its Gammabody platform. Their bispecific antibodies engage gamma delta T cells to elicit anti-tumor immune responses.
Last analyzed: Mar 17, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
LAVA Therapeutics N.V. (LVTX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy LVTX shares?
No. LVTX stopped trading on public markets in November 2025, so the shares are not available through a broker. Anything you see quoted for LVTX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before LVTX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to LAVA Therapeutics N.V.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.